to BioTechniques free email alert service to receive content updates.
POSTER
HTRF Ligand Binding Assay for the Chemokine Receptor CXCR4
Wendy Goodrich1, Gary Prescott1, Peter Banks1, François
Degorce2, Nicolas Pierre3
1:BioTek Instruments, Inc., Winooski, Vermont, USA • 2:Cisbio Bioassays, Bagnols-sur-Cèze, France • 3:Cisbio US, Bedford, Massachusetts, USA
Sponsored by BioTek Instruments GmbH Published in December 2010 2011 (p.6) DOI: 10.2144/000113597 Sponsored,vendor-submitted protocol
1:BioTek Instruments, Inc., Winooski, Vermont, USA • 2:Cisbio Bioassays, Bagnols-sur-Cèze, France • 3:Cisbio US, Bedford, Massachusetts, USA
Sponsored by BioTek Instruments GmbH Published in December 2010 2011 (p.6) DOI: 10.2144/000113597 Sponsored,vendor-submitted protocol
The chemokine receptor CXCR4 has multiple critical functions in normal
physiologies including embryonic development of the cardiovascular,
hemopoietic and central nervous systems. It has also been implicated in
disease pathologies such as HIV infection, cancer metastasis, leukemia
progression and rheumatoid arthritis, and is fueling the search for small
molecule CXCR4 antagonists as a means for intervention1. Here we demonstrate
the suitability of the Tag-lite HTRF technology for CXCR4 ligand binding
assays for high throughput screening applications. Automated assay
performance and pharmacology will be presented.
More Information
Do you have question about this Poster? Would you like more information about this poster?
Submit your questions here and BioTechniques will forward your question and contact information from our
database to an expert at
BioTek Instruments GmbH
Contact Information
Poster Categories
